サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193270

外科手術用接着剤市場：製品別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Surgical Glue Market By Product, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 290 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
外科手術用接着剤市場：製品別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 290 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

外科手術用接着剤の世界市場は、2021年に23億4,071万米ドルで、2022年から2031年にかけてCAGR7.0%を記録し、2031年には46億1,485万米ドルに達すると予測されています。

外科手術用接着剤は、フィブリノゲン、第XIII因子、フィブロネクチンを中心とする凝固タンパク質の凍結乾燥濃縮物（封止剤）と凍結乾燥トロンビン（触媒）の2つの成分が別々のバイアルに含まれています。第1成分は、組織の線溶を抑制するアプロチニン溶液で再構成されています。第二成分（トロンビン）は、500I.U.の濃度で入手可能な塩化カルシウムで溶解されます。ヒトフィブリンシーラントの適応は多数あり、すべての外科系に存在します。また、凝固障害を併発している患者の鼠径ヘルニア修復後の局所的な出血性合併症の予防にも有効です。

外科手術用接着剤の世界市場は、高齢者人口の増加、手術件数の増加、傷害の発生率の増加により、予測期間中に大きな市場成長を示すと予想されます。さらに、交通事故の増加、外科手術用接着剤に関する意識の高まり、慢性疾患の蔓延の増加が、市場成長に大きく寄与しています。しかし、外科手術用接着剤の高コストや代替品の入手性、低侵襲手術の不人気などが、市場成長にマイナスの影響を与えています。逆に、新興国における高い成長ポテンシャルは、市場成長のための有利な機会を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 外科手術用接着剤市場：製品別

  • 概要
    • 市場規模および予測
  • 天然
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 合成・半合成
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第5章 外科手術用接着剤市場：用途別

  • 概要
    • 市場規模および予測
  • 中枢神経系外科手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 一般外科手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 心臓血管外科手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 整形外科手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 美容外科手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 眼科手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 泌尿器科手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 肺手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第6章 外科手術用接着剤市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 病院
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 外来手術センター
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第7章 外科手術用接着剤市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測：製品別
    • 北米市場規模・予測：アプリケーション別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：製品別
    • 欧州市場規模・予測：アプリケーション別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他の欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：製品別
    • アジア太平洋地域の市場規模・予測：アプリケーション別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 日本
      • 中国
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：製品別
    • LAMEAの市場規模・予測：アプリケーション別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • LAMEAの残りの地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Cohera Medical, Inc.
  • CryoLife Inc.
  • CSL Limited
  • Johnson & Johnson
  • Ocular Therapeutix Inc.
  • Sanofi
  • Sealantis Ltd.
  • Vivostat
図表

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. SURGICAL GLUE MARKET FOR NATURAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. SURGICAL GLUE MARKET FOR NATURAL, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. SURGICAL GLUE MARKET FOR SYNTHETIC AND SEMI SYNTHETIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. SURGICAL GLUE MARKET FOR SYNTHETIC AND SEMI SYNTHETIC, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. SURGICAL GLUE MARKET FOR CENTRAL NERVOUS SYSTEM SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. SURGICAL GLUE MARKET FOR CENTRAL NERVOUS SYSTEM SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. SURGICAL GLUE MARKET FOR GENERAL SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. SURGICAL GLUE MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. SURGICAL GLUE MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. SURGICAL GLUE MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. SURGICAL GLUE MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. SURGICAL GLUE MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. SURGICAL GLUE MARKET FOR COSMETIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. SURGICAL GLUE MARKET FOR COSMETIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. SURGICAL GLUE MARKET FOR OPHTHALMIC SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. SURGICAL GLUE MARKET FOR OPHTHALMIC SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. SURGICAL GLUE MARKET FOR UROLOGICAL SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. SURGICAL GLUE MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. SURGICAL GLUE MARKET FOR PULMONARY SURGERIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. SURGICAL GLUE MARKET FOR PULMONARY SURGERIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. SURGICAL GLUE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. SURGICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. GLOBAL SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. SURGICAL GLUE MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. SURGICAL GLUE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. SURGICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. SURGICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. SURGICAL GLUE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. SURGICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. SURGICAL GLUE MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. NORTH AMERICA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. NORTH AMERICA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. NORTH AMERICA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. NORTH AMERICA SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. U.S. SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. U.S. SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. U.S. SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. CANADA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. CANADA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. CANADA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. MEXICO SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. MEXICO SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. MEXICO SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. EUROPE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. EUROPE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. EUROPE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. EUROPE SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. GERMANY SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. GERMANY SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. GERMANY SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. FRANCE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. FRANCE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. FRANCE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. UK SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. UK SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. UK SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. ITALY SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. ITALY SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. ITALY SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. SPAIN SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. SPAIN SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SPAIN SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. REST OF EUROPE SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. REST OF EUROPE SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF EUROPE SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. ASIA-PACIFIC SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. ASIA-PACIFIC SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. ASIA-PACIFIC SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. ASIA-PACIFIC SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. JAPAN SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. JAPAN SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. JAPAN SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. CHINA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. CHINA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. CHINA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. INDIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. INDIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. INDIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. AUSTRALIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. AUSTRALIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. AUSTRALIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH KOREA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SOUTH KOREA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. SOUTH KOREA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. LAMEA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. LAMEA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. LAMEA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. LAMEA SURGICAL GLUE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. BRAZIL SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. BRAZIL SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. BRAZIL SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 97. SAUDI ARABIA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 98. SAUDI ARABIA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 99. SAUDI ARABIA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 100. SOUTH AFRICA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 101. SOUTH AFRICA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 102. SOUTH AFRICA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 103. REST OF LAMEA SURGICAL GLUE MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 104. REST OF LAMEA SURGICAL GLUE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 105. REST OF LAMEA SURGICAL GLUE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 106.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 107.BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
  • TABLE 108.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 109.BAXTER INTERNATIONAL INC.: NET SALES
  • TABLE 110.BAXTER INTERNATIONAL INC.: KEY STRATERGIES
  • TABLE 111.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 112.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 113.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 114.B. BRAUN MELSUNGEN AG: NET SALES
  • TABLE 115.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
  • TABLE 116.COHERA MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 117.COHERA MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 118.COHERA MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 119.COHERA MEDICAL, INC.: NET SALES
  • TABLE 120.COHERA MEDICAL, INC.: KEY STRATERGIES
  • TABLE 121.CRYOLIFE INC.: COMPANY SNAPSHOT
  • TABLE 122.CRYOLIFE INC.: OPERATING SEGMENTS
  • TABLE 123.CRYOLIFE INC.: PRODUCT PORTFOLIO
  • TABLE 124.CRYOLIFE INC.: NET SALES
  • TABLE 125.CRYOLIFE INC.: KEY STRATERGIES
  • TABLE 126.CSL LIMITED: COMPANY SNAPSHOT
  • TABLE 127.CSL LIMITED: OPERATING SEGMENTS
  • TABLE 128.CSL LIMITED: PRODUCT PORTFOLIO
  • TABLE 129.CSL LIMITED: NET SALES
  • TABLE 130.CSL LIMITED: KEY STRATERGIES
  • TABLE 131.JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 132.JOHNSON & JOHNSON: OPERATING SEGMENTS
  • TABLE 133.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 134.JOHNSON & JOHNSON: NET SALES
  • TABLE 135.JOHNSON & JOHNSON: KEY STRATERGIES
  • TABLE 136.OCULAR THERAPEUTIX INC.: COMPANY SNAPSHOT
  • TABLE 137.OCULAR THERAPEUTIX INC.: OPERATING SEGMENTS
  • TABLE 138.OCULAR THERAPEUTIX INC.: PRODUCT PORTFOLIO
  • TABLE 139.OCULAR THERAPEUTIX INC.: NET SALES
  • TABLE 140.OCULAR THERAPEUTIX INC.: KEY STRATERGIES
  • TABLE 141.SANOFI: COMPANY SNAPSHOT
  • TABLE 142.SANOFI: OPERATING SEGMENTS
  • TABLE 143.SANOFI: PRODUCT PORTFOLIO
  • TABLE 144.SANOFI: NET SALES
  • TABLE 145.SANOFI: KEY STRATERGIES
  • TABLE 146.SEALANTIS LTD.: COMPANY SNAPSHOT
  • TABLE 147.SEALANTIS LTD.: OPERATING SEGMENTS
  • TABLE 148.SEALANTIS LTD.: PRODUCT PORTFOLIO
  • TABLE 149.SEALANTIS LTD.: NET SALES
  • TABLE 150.SEALANTIS LTD.: KEY STRATERGIES
  • TABLE 151.VIVOSTAT: COMPANY SNAPSHOT
  • TABLE 152.VIVOSTAT: OPERATING SEGMENTS
  • TABLE 153.VIVOSTAT: PRODUCT PORTFOLIO
  • TABLE 154.VIVOSTAT: NET SALES
  • TABLE 155.VIVOSTAT: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.SURGICAL GLUE MARKET SEGMENTATION
  • FIGURE 2.SURGICAL GLUE MARKET,2021-2031
  • FIGURE 3.SURGICAL GLUE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.SURGICAL GLUE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.SURGICAL GLUE MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NATURAL SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SYNTHETIC AND SEMI SYNTHETIC SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 15.SURGICAL GLUE MARKET,BY APPLICATION,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CENTRAL NERVOUS SYSTEM SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF GENERAL SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF COSMETIC SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OPHTHALMIC SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF UROLOGICAL SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PULMONARY SURGERIES SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 25.SURGICAL GLUE MARKET,BY END USER,2021(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF OTHERS SURGICAL GLUE MARKET,2021-2031(%)
  • FIGURE 29.SURGICAL GLUE MARKET BY REGION,2021
  • FIGURE 30.U.S. SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 31.CANADA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 32.MEXICO SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 33.GERMANY SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 34.FRANCE SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 35.UK SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 36.ITALY SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 37.SPAIN SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 38.REST OF EUROPE SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 39.JAPAN SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 40.CHINA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 41.INDIA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 42.AUSTRALIA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH KOREA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF ASIA-PACIFIC SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 45.BRAZIL SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 46.SAUDI ARABIA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 47.SOUTH AFRICA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 48.REST OF LAMEA SURGICAL GLUE MARKET,2021-2031($MILLION)
  • FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 53.COMPETITIVE DASHBOARD
  • FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 55.BAXTER INTERNATIONAL INC..: NET SALES ($MILLION)
  • FIGURE 56.B. BRAUN MELSUNGEN AG.: NET SALES ($MILLION)
  • FIGURE 57.COHERA MEDICAL, INC..: NET SALES ($MILLION)
  • FIGURE 58.CRYOLIFE INC..: NET SALES ($MILLION)
  • FIGURE 59.CSL LIMITED.: NET SALES ($MILLION)
  • FIGURE 60.JOHNSON & JOHNSON.: NET SALES ($MILLION)
  • FIGURE 61.OCULAR THERAPEUTIX INC..: NET SALES ($MILLION)
  • FIGURE 62.SANOFI.: NET SALES ($MILLION)
  • FIGURE 63.SEALANTIS LTD..: NET SALES ($MILLION)
  • FIGURE 64.VIVOSTAT.: NET SALES ($MILLION)
目次
Product Code: A31580

The global surgical glue market was valued at $2,340.71 million in 2021, and is projected to reach $4,614.85 million by 2031, registering a CAGR of 7.0% from 2022 to 2031.

Surgical glue is made of two components contained in separate vials; a freeze dried concentrate of clotting proteins, mainly fibrinogen, Factor XIII and fibronectin (the sealant) and freeze dried thrombin (the catalyst). The first component is reconstituted with an aprotinin solution that inhibits tissue fibrinolysis. The second component (thrombin) is dissolved with calcium chloride that is available in 500 I.U. concentration. Indications for the use of human fibrin sealant are numerous and present in all surgical branches. It is also effective in preventing local hemorrhagic complications after inguinal hernia repair in patients with concurrent coagulation disorders.

The global surgical glue market is anticipated to show significant market growth during the forecast period, owing to increase in geriatric population, increase in number of surgical procedures performed, and increase in incidence of wounds and injuries. Furthermore, increase in number of road accidents, increase in awareness regarding surgical glue and increase in prevalence of chronic diseases are considerably contributing toward the market growth. However, high cost of surgical glues and availability of alternate products and unpopularity of minimally invasive surgeries are negatively impacting the market growth. Conversely, the high growth potential in emerging countries offers lucrative opportunities for growth of the market.

The global surgical glue market is segmented on the basis of product, application, end user, and region. By product, the market is classified into natural and synthetic & semi-synthetic. By application, it is classified into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. By end user, it is classified into hospitals, ambulatory surgery centers, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major companies profiled in the report include Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Integra Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Ocular Therapeutix Inc., and OptMed, Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical glue market analysis from 2021 to 2031 to identify the prevailing surgical glue market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the surgical glue market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global surgical glue market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Product

  • Natural
  • Synthetic and Semi Synthetic

By Application

  • Central Nervous System Surgeries
  • General Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Cosmetic Surgeries
  • Ophthalmic Surgeries
  • Urological Surgeries
  • Pulmonary Surgeries
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Cohera Medical, Inc.
    • CryoLife Inc.
    • CSL Limited
    • Johnson & Johnson
    • Ocular Therapeutix Inc.
    • Sanofi
    • Sealantis Ltd.
    • Vivostat

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SURGICAL GLUE MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Natural
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Synthetic and Semi Synthetic
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: SURGICAL GLUE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Central Nervous System Surgeries
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 General Surgeries
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4 Cardiovascular Surgeries
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5 Orthopedic Surgeries
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country
  • 5.6 Cosmetic Surgeries
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market share analysis by country
  • 5.7 Ophthalmic Surgeries
    • 5.7.1 Key market trends, growth factors and opportunities
    • 5.7.2 Market size and forecast, by region
    • 5.7.3 Market share analysis by country
  • 5.8 Urological Surgeries
    • 5.8.1 Key market trends, growth factors and opportunities
    • 5.8.2 Market size and forecast, by region
    • 5.8.3 Market share analysis by country
  • 5.9 Pulmonary Surgeries
    • 5.9.1 Key market trends, growth factors and opportunities
    • 5.9.2 Market size and forecast, by region
    • 5.9.3 Market share analysis by country
  • 6.0 Others
    • 6.0.1 Key market trends, growth factors and opportunities
    • 6.0.2 Market size and forecast, by region
    • 6.0.3 Market share analysis by country

CHAPTER 6: SURGICAL GLUE MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: SURGICAL GLUE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.1.4 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.2.4 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product
      • 7.2.5.3.3 Market size and forecast, by Application
      • 7.2.5.3.4 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.1.4 Market size and forecast, by End user
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.2.4 Market size and forecast, by End user
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.3.4 Market size and forecast, by End user
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.4.4 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.5.4 Market size and forecast, by End user
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.6.4 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.1.4 Market size and forecast, by End user
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.2.4 Market size and forecast, by End user
      • 7.4.5.3 India
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.3.4 Market size and forecast, by End user
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.4.4 Market size and forecast, by End user
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.5.4 Market size and forecast, by End user
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.6.4 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.1.4 Market size and forecast, by End user
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.2.4 Market size and forecast, by End user
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.3.4 Market size and forecast, by End user
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product
      • 7.5.5.4.3 Market size and forecast, by Application
      • 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Baxter International Inc.
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 B. Braun Melsungen AG
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Cohera Medical, Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 CryoLife Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 CSL Limited
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Johnson & Johnson
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Ocular Therapeutix Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Sanofi
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Sealantis Ltd.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Vivostat
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments